Streetbeat News

Products Services

AMZN

Amazon Pharmacy is expanding its services to 20 more U.S. cities by 2025, offering same-day delivery of prescription medications. This expansion aims to address 'pharmacy deserts' and improve access to healthcare. Amazon's stock saw a slight increase following the announcement.

Portfolio Pulse from Vandana Singh

October 10, 2024 | 12:25 pm

TRNR

Interactive Strength's shares rose following Chuze Fitness's order of multiple CLMBRs for four pilot locations, indicating potential growth and increased market presence for Interactive Strength.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:24 pm

MTEK

Maris-Tech is expanding into the U.S. market by establishing a new subsidiary, Maris North America, to enhance its growth in the defense and homeland security sectors. The company is partnering with experienced consultants to accelerate its U.S. expansion and strengthen its local presence.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:20 pm

DAL

Delta Air Lines reported mixed Q3 results with a slight revenue beat but missed EPS expectations. The company faced a $380 million revenue hit due to a tech outage. Despite challenges, Delta's balance sheet received an investment-grade upgrade, and the company anticipates a strong Q4 with a 30% increase in pre-tax profit.

Portfolio Pulse from Akanksha Bakshi

October 10, 2024 | 12:20 pm

PLMR

The Mechanic Group has partnered with Palomar to enhance their security alarm and investigator program. This partnership aims to offer tailored general liability and umbrella coverage for the security and alarm industry.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:19 pm

XNCR

Xencor has presented preclinical data on XmAb942, a high-potency anti-TL1A antibody aimed at treating inflammatory bowel diseases. A Phase 1 study in healthy volunteers is scheduled to start in Q4 2024, with initial data expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:18 pm

CMND

Clearmind Medicine's shares rise following Institutional Review Board approval for a Phase I/IIa clinical trial in the U.S. targeting alcohol use disorder.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:15 pm

ACHV

Achieve Life Sciences has completed the enrollment of 479 participants in its ORCA-OL clinical trial and reported that the first Data Safety Monitoring Committee review found no safety concerns.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:14 pm

CMND

Clearmind Medicine has received Institutional Review Board approval for its FDA clinical trial of CMND-100 at a second clinical site, focusing on treating alcohol use disorder.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:12 pm

BTOC

Armlogi has announced a significant upgrade to its API, now at version 3.5, and has fully integrated with Temu's Warehouse Management System. This integration allows Armlogi to handle over 3,000 Temu orders daily, amid increasing user engagement and service requests.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:11 pm